AKSA PHARMA

Active

Private limited companyfounded 201610 yrs activeAraucarialaan 79, 1020 Brussel, BelgiumKBO/BCE: BE 0651.787.243

The computed 12-month bankruptcy probability of AKSA PHARMA is 2.0% (moderate). The 2024 annual accounts show equity of €157k and a net result of €-54k. The figures fluctuate too strongly year-on-year for a reliable trend projection. Its solvency ranks better than 47% of 6537 sector peers (fiscal year 2024). The company has been active since 2016 and the Belgian State Gazette contains no insolvency or warning signals.

Watch Print / PDF

Checked score

Score 2024

35 / 100

Weak

The score weighs solvency, liquidity and profitability. Bankruptcy probability contributes 35%. Every signal that weighs is under Signals.

Axes · tick = 2023

Profitability6▼-94

Solvency55▼-4

Growth52▼-26

Track record100

Bankruptcy probability, 12 months

2.0% Moderate

0%0.5%1.5%4%10%≥ 25%

Credit up to €5k at 30 days only on tighter terms

Liquidity short (current ratio 0.96 against 1.13 in 2023; short-term debt: 70.1% and cash: 0.3% of total assets), and 70.1% of the assets are financed with debt.

How do we compute the score and the probability?

Credit advice for your own amount and term

Signals

Five signals. The signal on the left, the evidence on the right.

+raises risk○neutral

Higher-failure-rate region

In this region companies fail more often than in the rest of the country.

KBO · registered office

Higher-failure-rate sector

In this sector companies fail more often than the Belgian average.

Gazette · bankruptcies per sector, NACE 47

Relative position

BE, all sectors

reference

Sector 47

higher

← fewer bankruptcies more bankruptcies →

Annual accounts: weaker financial profile

The latest annual accounts show a weaker profile in solvency, result or liquidity than companies that stay afloat.

NBB · annual accounts 2024

Solvency, return and age of the figures

Solvency

29.9%

Return on assets

-10.3%

Age of the figures

21 mo

Filed more than 90 days late

The financial year that closed on 31-12-2024 was due by 31-07-2025 and was filed on 23-06-2026, 327 days past the deadline. Measured on financial year 2023: companies more than 90 days late are in an abnormal legal state today in 5.61% of cases, against 1.66% across all filers.

NBB · 8 filings

Deviation from the deadline

2025

not confirmed

2024

327 d late

2023

32 d late

2022

36 d late

2021

45 d late

2020

51 d late

2019

119 d late

← before the deadline after the deadline →

No strike-offs in the KBO publications

We found no ex-officio strike-off or cessation. Our series starts in 2021 and has gaps, so this is not a confirmation that there is nothing.

KBO publications · our coverage

Financials · fiscal year 2024, full schema

Turnover

Not included in this filing

EBIT margin

Not included in this filing

Net result

€-54k

2023 · €155k

2018: €-12k 2019: €-150k 2020: €-37k 2021: €74k 2022: €168k 2023: €155k

2018 → 2024

Working capital

€-15k

2023 · €52k

2018: €-16k 2019: €-63k 2020: €-151k 2021: €-147k 2022: €-57k 2023: €52k

2018 → 2024

Multi-year overview

Every figure with its change against the year before

▲ rise ▼ fall

Line20202021202220232024Trend

Equity€-187k-€-112k▲ 39.8%€56k€211k▲ 275%€157k▼ 25.7%

Operating result€-30k-€84k€198k▲ 137%€224k▲ 13.1%€-40k

Net result€-37k-€74k€168k▲ 127%€155k▼ 8.3%€-54k

Result per fiscal year

Operating resultNet result

The operating result turns negative in 2024: a loss of €40k after €224k in 2023, the lowest result in the available series.

Balance-sheet composition

2024 in colour, 2023 as the grey bar beneath

Assets €524k

32.8%

67.2%

Fixed assets €172k▲ 3.6%

Current assets €352k▼ 23.7%

Equity and liabilities €524k

29.9%

70.1%

Equity €157k▼ 25.7%

Debt €368k▼ 11.9%

The debt ratio rises from 66.4% to 70.1%. Equity and debt are lower.

Key figures and ratios

2024 value · change against 2023

EBITDA

€-11k▼

2023 · €255k

Cash flow

€-25k▼

2023 · €185k

Solvency

29.9%▼

2023 · 33.6%

Current ratio

0.96▼

2023 · 1.13

Quick ratio

0.35▲

2023 · 0.23

Debt / equity

2.35▲

2023 · 1.98

ROE

-34.5%▼

2023 · 73.4%

ROA

-10.3%▼

2023 · 24.6%

Interest coverage

-0.83▼

2023 · 21.72

Debt

€368k▼

2023 · €417k

Debt ≤ 1 year

€368k▼

2023 · €410k

Staff costs

€185k▲

2023 · €184k

Green means a favourable move, even when the figure itself falls: as with debt or debt / equity.

Filed annual accounts

As filed with the NBB · 2024 against 2023

Balance sheet Code20232024

Assets

Total assets20/58€628k€524k▼

Fixed assets21/28€166k€172k▲

Intangible fixed assets21€9k€42k▲

Tangible fixed assets22/27€139k€112k▼

Plant, machinery and equipment23€139k€112k▼

Financial fixed assets28€18k€18k=

Current assets29/58€462k€352k▼

Stocks and contracts in progress3€366k€225k▼

Stocks30/36€366k€225k▼

Amounts receivable within one year40/41€46k€123k▲

Trade receivables40€27k€96k▲

Other amounts receivable41€19k€27k▲

Cash at bank and in hand54/58€50k€1k▼

Deferred charges and accrued income490/1€339€2k▲

Equity and liabilities

Total equity and liabilities10/49€628k€524k▼

Equity10/15€211k€157k▼

Contributions10/11€19k€19k=

Outside capital11€19k€19k=

Other1109/19€19k€19k=

Profit (loss) carried forward14€192k€138k▼

Amounts payable17/49€417k€368k▼

Amounts payable after more than one year17€7k-

Financial debts170/4€7k-

Amounts payable within one year42/48€410k€368k▼

Current portion of amounts payable after more than one year42€71k€70k▼

Financial debts43-€30k

Credit institutions430/8-€30k

Trade debts44€182k€172k▼

Suppliers440/4€182k€172k▼

Taxes, remuneration and social security45€122k€56k▼

Taxes450/3€80k€1k▼

Remuneration and social security454/9€42k€55k▲

Other amounts payable47/48€35k€40k▲

Income statement Code20232024

Remuneration, social security and pensions62€184k€185k▲

Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets630€30k€29k▼

Other operating charges640/8€7-

Gross operating margin9900€438k€174k▼

Operating profit (loss)9901€224k€-40k▼

Financial charges65/66B€12k€14k▲

Recurring financial charges65€12k€14k▲

Profit (loss) for the period before taxes9903€213k€-54k▼

Income taxes67/77€58k-

Profit (loss) for the period9904€155k€-54k▼

Profit (loss) for the period to be appropriated9905€155k€-54k▼

Appropriation of the result

Profit (loss) to be appropriated9906€192k€138k▼

Profit (loss) brought forward from the previous period14P€38k€192k▲

Social balance

Average headcount (FTE)90873.03.6▲

The notes to these accounts (9 items: statements of assets and debts, cost breakdowns, rights and commitments) are not shown here.

Download as CSV

Timeline · acts, filings and financial milestones

All 12Financial 4Filings 8

2026

23-06

NBB filing Annual accounts filed

fiscal year 2024 · full schema · 327 days late

2024

01-09

NBB filing Annual accounts filed

fiscal year 2023 · full schema · 32 days late

2023

31-12

Financial Equity above €200kEq €211k ▲275%

3 profitable years in a row build equity to €211k.

05-09

NBB filing Annual accounts filed

fiscal year 2022 · full schema · 36 days late

2022

31-12

Financial Highest result since 2018net €168k ▲127%

Net result €168k, the highest in the series.

14-09

NBB filing Annual accounts filed

fiscal year 2021 · micro schema · 45 days late

2021

31-12

Financial Back to profitnet €74k

Net result €74k after 3 loss-making years.

20-09

NBB filing Annual accounts filed

fiscal year 2020 · micro schema · 51 days late

2020

27-11

NBB filing Annual accounts filed

fiscal year 2019 · micro schema · 119 days late

2019

31-12

Financial Weakest financial yearnet €-150k

Net result drops to €-150k, the lowest in the series; recovery starts the following year.

07-08

NBB filing Annual accounts filed

fiscal year 2018 · micro schema · 7 days late

2018

27-06

NBB filing Annual accounts filed

fiscal year 2017 · micro schema

Financial milestoneNBB filingFinancial milestones sit on the fiscal year-end date, not the filing date.

Directors · office · real estate

Directors

no sitting director, no change since 2023

We have established no sitting directors for this company. We derive directors from published Gazette acts; while there are none, or none read, nothing appears here. That does not mean the company has none: the CBE keeps its own list of function holders, which we do not read.

17-11-2023 BONTEMPS Richard: Resigned as Managing director

01-08-2018 Khemais Ben Mohamed BEN SASSI: Resigned as Managing director

Location & real-estate footprint

Registered office, Brussel · 1 establishment unit since 2016

establishment The establishment unit on the map

Cannot be placed on the map

This address could not be matched to a point in the Belgian address register (BOSA BEST). The address below comes straight from the Crossroads Bank.

Araucarialaan 791020 Brussel

Ground area

5.2 ha

Building footprint

1.2 ha